MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Heatmap
  • Русский
  • 中文
  • Español
  • Português
  • 日本語
  • Deutsch
  • 한국어
  • Français
  • Italiano
  • Türkçe
Spero Therapeutics, Inc. Common Stock

SPRO

#4032
Spero Therapeutics, Inc. - Common Stock
1.1 5 USD
-0.03%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
1.15
1.20
Year Range
1.08
3.08
Daily Change
-2.54%
Monthly Change
+1.77%
6 month change
-59.51%
Year Change
-48.66%
Previous Close
1.1 8
Open
1.1 9
Low
1.1 5
High
1.2 0
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. Biotechnology
  5. SPRO
Open full chart

Financials

Overview Statement Statistics Documents

2017

Quarterly report, Q3 FY2017

2017.12.14
Spero Therapeutics, Inc. quarterly report, Q3 FY2017
10-Q
  • 1
  • ...
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16

News

Seeking Alpha
SPRO
2026.08.13

Spero Therapeutics, Inc. (SPRO) Q2 2026 Earnings Call Transcript

Seeking Alpha
AZN AAPL MSFT META MA
2026.07.25

Big Tech Earnings, Fed's Interest Rate Decision To Keep Next Week Busy

Seeking Alpha
SPRO
2026.07.14

Spero Therapeutics: "Buy" Utebzi Royalty Deal For Funding And SP001 In-Licensing (SPRO)

Seeking Alpha
SPRO GSK
2026.06.18

Spero Therapeutics: Yesterday's Selloff On Utebzi Approval Seems Bewildering (NASDAQ:SPRO)

Zacks
GSK PFE MRK SPRO
2026.06.18

GSK's Utebzi Wins FDA Nod for Complicated Urinary Tract Infections

Seeking Alpha
SPRO
2026.06.08

Spero Therapeutics: Approval Upside, Commercial Friction (Initiating Hold)

Zacks
GSK JNJ IONS SPRO
2026.04.29

GSK Q1 Earnings Beat Estimates, Specialty Medicines Drive Sales Growth

Seeking Alpha
SPRO
2026.02.11

Spero Therapeutics: Tebipenem’s FDA Path Supports A Speculative Buy (NASDAQ:SPRO)

Investing
SPRO
2026.02.10

Keutzer, Spero Therapeutics COO, sells $44k in shares

Investing
SPRO
2026.02.10

Spero Therapeutics CEO sells $207k in stock

Zacks
GSK JNJ IONS SPRO
2026.02.04

GSK's Q4 Earnings & Sales Beat Estimates, Stock Up on '26 Outlook

Investing
SPRO
2026.01.31

Spero Therapeutics announces board resignation and SEC investigation closure

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Store
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stocks
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Subscribe to algo trading news
Risk Disclosure Terms of Use Help Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd